Neuromodulation Devices Market
Neuromodulation Devices Market Forecasts to 2032 – Global Analysis By Product Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Transcranial Magnetic Stimulators, and Other Product Types), Indication, MRI Compatibility, Biomaterial, End User and By Geography
According to Stratistics MRC, the Global Neuromodulation Devices Market is accounted for $2.2 billion in 2025 and is expected to reach $12.0 billion by 2032 growing at a CAGR of 5.0% during the forecast period. Neuromodulation devices are medical technologies designed to alter nerve activity by delivering targeted stimuli, such as electrical impulses or chemical agents, to specific nerves or neurological sites. These devices modify abnormal nerve signals to restore or normalize nervous system functions, often used to relieve symptoms like chronic pain, movement disorders, or neurological dysfunctions. The stimulation can adjust nerve excitability or pathways, providing therapeutic effects by influencing nerve communication directly.
According to the Epilepsy Foundation of America and World Health Organization (WHO), an estimated 50 million people globally were suffering from epilepsy.
Market Dynamics:
Driver:
Increasing prevalence of chronic neurological diseases
The growing incidence of neurological disorders such as Parkinson’s disease, epilepsy, Alzheimer’s, and chronic pain syndromes is a key driver for the neuromodulation devices market. With aging populations and lifestyle-related complications on the rise, demand for minimally invasive, long-term therapeutic solutions is increasing. Neuromodulation devices offer targeted, reversible, and programmable therapy, making them attractive alternatives to pharmaceuticals. The rising burden of neurological conditions is pushing healthcare systems and practitioners to adopt these innovative treatment modalities.
Restraint:
High cost of neuromodulation devices
The significant cost associated with neuromodulation devices, including implantation, maintenance, and programming, poses a major barrier to widespread adoption. High initial investment, coupled with limited reimbursement coverage in several regions, restricts access, especially in low- and middle-income countries. Additionally, follow-up visits, battery replacements, and device-related services further inflate long-term treatment costs. These economic limitations discourage adoption in non-critical cases and delay therapy for patients without sufficient insurance or government support.
Opportunity:
Growing awareness and acceptance of neuromodulation therapies
Increased awareness of non-pharmacological pain and neurological treatments has led to rising acceptance of neuromodulation therapies across both patients and healthcare providers. Educational campaigns, clinical success stories, and expanding clinical evidence are building trust in device-based therapies. Furthermore, the shift toward personalized and precision medicine supports neuromodulation’s appeal. As stigma around implantable devices decreases and technology becomes more accessible, new patient demographics are entering the market, especially in regions previously underserved by advanced neuro-interventions.
Threat:
Risk of device-associated complications and side effects
Potential risks such as infections, lead migration, hardware malfunction, and stimulation-related side effects remain concerns that threaten the market's expansion. These complications may lead to device revision or explantation, increasing patient discomfort and treatment costs. Moreover, apprehensions about surgical implantation, long-term dependence, and possible interference with other bodily systems can deter both patients and physicians. Negative outcomes or high-profile product recalls could also impact public confidence in neuromodulation technologies.
Covid-19 Impact:
The COVID-19 pandemic initially disrupted elective neuromodulation procedures due to lockdowns and resource reallocation toward critical care. Many patients delayed surgeries, leading to short-term declines in sales and implant volumes. However, post-pandemic recovery has been fueled by a renewed focus on chronic condition management and growing demand for outpatient-based treatments. Telehealth and remote device programming solutions also emerged as valuable tools, ensuring continuity of care and reshaping service delivery models in the neuromodulation sector.
The spinal cord stimulators segment is expected to be the largest during the forecast period
The spinal cord stimulators segment is expected to account for the largest market share during the forecast period propelled by the high prevalence of chronic back and leg pain disorders. These devices are widely used in treating failed back surgery syndrome and complex regional pain syndrome, with proven long-term efficacy. Continuous product innovations, such as closed-loop systems and wireless programming, enhance treatment outcomes and patient compliance. Moreover, favorable reimbursement policies in key markets further support the large-scale adoption of spinal cord stimulators.
The deep brain stimulators segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the deep brain stimulators segment is predicted to witness the highest growth rate, influenced by increasing demand for advanced therapies in managing Parkinson’s disease, dystonia, and essential tremor. Technological advancements in targeting precision and programming flexibility are improving patient outcomes. Furthermore, growing research in psychiatric and neuropsychiatric applications, including depression and OCD, is expanding the scope of deep brain stimulation. As clinical indications widen, the segment is positioned for accelerated global growth.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, fuelled by, rising neurological disorder prevalence, growing healthcare expenditure, and increasing adoption of advanced medical technologies. Countries like China, Japan, and India are investing heavily in neurology infrastructure and device-based therapies. Moreover, growing patient awareness, expanding private healthcare networks, and supportive government initiatives in neurorehabilitation drive regional demand. The large population base and ongoing urbanization further strengthen Asia Pacific’s dominance in the neuromodulation devices market.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by, rising neurological disorder prevalence, growing healthcare expenditure, and increasing adoption of advanced medical technologies. Countries like China, Japan, and India are investing heavily in neurology infrastructure and device-based therapies. Moreover, growing patient awareness, expanding private healthcare networks, and supportive government initiatives in neurorehabilitation drive regional demand. The large population base and ongoing urbanization further strengthen Asia Pacific’s dominance in the neuromodulation devices market.
Key players in the market
Some of the key players in Neuromodulation Devices Market include Medtronic, Boston Scientific Corporation, Stryker, Abbott, B. Braun Melsungen AG, NEVRO CORP., NeuroSigma, Inc, NeuroPace, Inc., Soterix Medical Inc, Synapse Biomedical Inc, ReShape Lifesciences, Inc, Bioness Inc., ALEVA NEUROTHERAPEUTICS SA, LivaNova PLC, Neuronetics, Cyberonics, Inc., Neuromod, and Axonics, Inc.
Key Developments:
In July 2025, Boston Scientific received FDA approval for two new SCS leads—Linear 3-4 and Linear 3-6—for its Precision Plus SCS System, expanding percutaneous lead configuration options in the market.
In April 2025, Abbott introduced a next-generation delivery system for its Proclaim™ DRG neurostimulation—the first FDA-approved DRG technology for treating complex regional pain syndrome (CRPS) types 1 & 2—designed to streamline electrode placement to the dorsal root ganglion.
In January 2025, Medtronic achieved CE mark approval for its BrainSense Adaptive Deep Brain Stimulation (aDBS) and Electrode Identifier systems—a significant milestone enabling personalized, sensing-enabled care for Parkinson’s patients in Europe.
Product Types Covered:
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Transcranial Magnetic Stimulators
• Other Product Types
Indications Covered:
• Chronic Pain
• Dystonia
• Epilepsy
• Essential Tremor
• Heart Failure
• Major Depressive Disorder
• Parkinson’s Disease
• Obsessive-Compulsive Disorder
• Overactive Bladder
• Sleep Apnea
MRI Compatibilities Covered:
• MRI Compatible
• MRI Non-Compatible
Biomaterials Covered:
• Metallic Biomaterials
• Polymeric Biomaterials
• Ceramic Biomaterials
End Users Covered:
• Hospital
• Neurological Clinics
• Home Healthcare
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Neuromodulation Devices Market, By Product Type
5.1 Introduction
5.2 Spinal Cord Stimulators
5.3 Deep Brain Stimulators
5.4 Sacral Nerve Stimulators
5.5 Vagus Nerve Stimulators
5.6 Transcranial Magnetic Stimulators
5.7 Other Product Types
6 Global Neuromodulation Devices Market, By Indication
6.1 Introduction
6.2 Chronic Pain
6.3 Dystonia
6.4 Epilepsy
6.5 Essential Tremor
6.6 Heart Failure
6.7 Major Depressive Disorder
6.8 Parkinson’s Disease
6.9 Obsessive-Compulsive Disorder
6.10 Overactive Bladder
6.11 Sleep Apnea
7 Global Neuromodulation Devices Market, By MRI Compatibility
7.1 Introduction
7.2 MRI Compatible
7.3 MRI Non-Compatible
8 Global Neuromodulation Devices Market, By Biomaterial
8.1 Introduction
8.2 Metallic Biomaterials
8.3 Polymeric Biomaterials
8.4 Ceramic Biomaterials
9 Global Neuromodulation Devices Market, By End User
9.1 Introduction
9.2 Hospital
9.3 Neurological Clinics
9.4 Home Healthcare
10 Global Neuromodulation Devices Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Medtronic
12.2 Boston Scientific Corporation
12.3 Stryker
12.4 Abbott
12.5 B. Braun Melsungen AG
12.6 NEVRO CORP.
12.7 NeuroSigma, Inc
12.8 NeuroPace, Inc.
12.9 Soterix Medical Inc
12.10 Synapse Biomedical Inc
12.11 ReShape Lifesciences, Inc
12.12 Bioness Inc.
12.13 ALEVA NEUROTHERAPEUTICS SA
12.14 LivaNova PLC
12.15 Neuronetics
12.16 Cyberonics, Inc.
12.17 Neuromod
12.18 Axonics, Inc.
List of Tables
1 Global Neuromodulation Devices Market Outlook, By Region (2024-2032) ($MN)
2 Global Neuromodulation Devices Market Outlook, By Product Type (2024-2032) ($MN)
3 Global Neuromodulation Devices Market Outlook, By Spinal Cord Stimulators (2024-2032) ($MN)
4 Global Neuromodulation Devices Market Outlook, By Deep Brain Stimulators (2024-2032) ($MN)
5 Global Neuromodulation Devices Market Outlook, By Sacral Nerve Stimulators (2024-2032) ($MN)
6 Global Neuromodulation Devices Market Outlook, By Vagus Nerve Stimulators (2024-2032) ($MN)
7 Global Neuromodulation Devices Market Outlook, By Transcranial Magnetic Stimulators (2024-2032) ($MN)
8 Global Neuromodulation Devices Market Outlook, By Other Product Types (2024-2032) ($MN)
9 Global Neuromodulation Devices Market Outlook, By Indication (2024-2032) ($MN)
10 Global Neuromodulation Devices Market Outlook, By Chronic Pain (2024-2032) ($MN)
11 Global Neuromodulation Devices Market Outlook, By Dystonia (2024-2032) ($MN)
12 Global Neuromodulation Devices Market Outlook, By Epilepsy (2024-2032) ($MN)
13 Global Neuromodulation Devices Market Outlook, By Essential Tremor (2024-2032) ($MN)
14 Global Neuromodulation Devices Market Outlook, By Heart Failure (2024-2032) ($MN)
15 Global Neuromodulation Devices Market Outlook, By Major Depressive Disorder (2024-2032) ($MN)
16 Global Neuromodulation Devices Market Outlook, By Parkinson’s Disease (2024-2032) ($MN)
17 Global Neuromodulation Devices Market Outlook, By Obsessive-Compulsive Disorder (2024-2032) ($MN)
18 Global Neuromodulation Devices Market Outlook, By Overactive Bladder (2024-2032) ($MN)
19 Global Neuromodulation Devices Market Outlook, By Sleep Apnea (2024-2032) ($MN)
20 Global Neuromodulation Devices Market Outlook, By MRI Compatibility (2024-2032) ($MN)
21 Global Neuromodulation Devices Market Outlook, By MRI Compatible (2024-2032) ($MN)
22 Global Neuromodulation Devices Market Outlook, By MRI Non-Compatible (2024-2032) ($MN)
23 Global Neuromodulation Devices Market Outlook, By Biomaterial (2024-2032) ($MN)
24 Global Neuromodulation Devices Market Outlook, By Metallic Biomaterials (2024-2032) ($MN)
25 Global Neuromodulation Devices Market Outlook, By Polymeric Biomaterials (2024-2032) ($MN)
26 Global Neuromodulation Devices Market Outlook, By Ceramic Biomaterials (2024-2032) ($MN)
27 Global Neuromodulation Devices Market Outlook, By End User (2024-2032) ($MN)
28 Global Neuromodulation Devices Market Outlook, By Hospital (2024-2032) ($MN)
29 Global Neuromodulation Devices Market Outlook, By Neurological Clinics (2024-2032) ($MN)
30 Global Neuromodulation Devices Market Outlook, By Home Healthcare (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
